By Amanda Bronstad | July 26, 2022
Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.
By Amanda Bronstad | July 5, 2022
U.S. District Judge David Faber, in a bench trial that concluded last year in the Southern District of West Virginia, sided with distributors McKesson, Cardinal Health and AmerisourceBergen in a 184-page decision about the opioid crisis.
By Amanda Bronstad | June 27, 2022
Monday's settlement comes after the Oklahoma Supreme Court reversed a $465 million judgment the state obtained against manufacturer Johnson & Johnson's Janssen Pharmaceuticals.
By Scott Graham | June 14, 2022
The Federal Circuit ruled that a patent on a CAR-T treatment did not meet patent law's written description requirement. Jones Day and Irell & Manella are arguing for Bristol-Myers Squibb that the Federal Circuit has added judicial requirements to the statute that are virtually impossible for life sciences companies to meet.
By Allison Dunn | June 7, 2022
The court ruled "the policies underpinning the learned intermediary doctrine remain true today."
By Scott Graham | June 6, 2022
Three Federal Circuit judges suggest that the language of the Patent Act limits inventors to human beings. Judge Richard Taranto adds that it's "not self-evident" that extending inventorship to machines would be good policy, either.
By Mason Lawlor | May 6, 2022
The Department of Justice, along with state law enforcement, has brought criminal charges against 14 defendants, 12 of them medical professionals, for the illegal sale of opioids.
By Amanda Bronstad | May 5, 2022
Another opioid trial began on April 25 in San Francisco against Walgreens, as well as manufacturers Allergan and Teva, and Teva's distribution subsidiary Anda.
By Amanda Bronstad | May 3, 2022
Tuesday's announcement, from Attorney General Bob Ferguson, comes after the state wrapped up a bench trial against the distributors last month but before King County Superior Court Judge Michael Scott had ruled on the case.
By Jane Wester | April 29, 2022
A Davis Polk attorney representing Purdue argued that the third-party release should be approved, because it is a way of maximizing recovery for people affected by the opioid crisis.
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS